The serine/threonine kinase AKT is one of the most frequently activated oncoprotein in human cancer, with its critical role in breast cancer tumorigenesis and tumor development being supported by extensive studies in human cancers and mouse models (Fruman et al., 2017; Hoxhaj and Manning, 2020). The gene discussed is MARK2; the disease is cancer.